Literature DB >> 11353814

ADP-ribosylation factor-dependent phospholipase D activation by VPAC receptors and a PAC(1) receptor splice variant.

D A McCulloch1, E M Lutz, M S Johnson, D N Robertson, C J MacKenzie, P J Holland, R Mitchell.   

Abstract

The VPAC(1) and VPAC(2) receptors for vasoactive intestinal polypeptide and the PAC(1) receptor for pituitary adenylate cyclase-activating polypeptide are members of a subfamily of G protein-coupled receptors (GPCRs). We recently reported that phospholipase D (PLD) activation by members of the rhodopsin group of GPCRs occurs by at least two routes, one of which seems to involve the small G protein ADP-ribosylation factor (ARF) and its physical association with GPCRs. Here we report that rat VPAC and PAC(1) receptors can also stimulate PLD (albeit less potently than adenylate cyclase) in transfected cells and also in cells where they are natively expressed. PLD responses of the VPAC receptors and the hop1 spice variant of the PAC(1) receptor but not its null form are sensitive to brefeldin A (BFA), an inhibitor of GTP exchange at ARF. The presence of the hop1 cassette in the rat PAC(1) receptor facilitates PLD activation in the absence of marked changes in ligand binding, receptor internalization, and adenylate cyclase activation, with some reduction in phospholipase C activation. Both VPAC(2) and PAC(1-hop1) (but not PAC(1-null)) receptors were shown to associate with immunoprecipitates directed against native or epitope-tagged ARF. A chimeric construct of the VPAC(2) receptor body with intracellular loop 3 (i3) of the PAC(1-null) receptor mediated BFA-insensitive activation of PLD, whereas the response of the corresponding PAC(1-hop1) construct was BFA-sensitive. Motifs in i3 of the PAC(1-hop1) receptor may act as critical determinants of coupling to ARF-dependent PLD activation by contributing to the GPCR:ARF interface.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11353814     DOI: 10.1124/mol.59.6.1523

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  11 in total

1.  Pituitary Adenylate Cyclase-Activating Polypeptide Receptors Signal via Phospholipase C Pathway to Block Apoptosis in Newborn Rat Retina.

Authors:  Monika Lakk; Viktoria Denes; Robert Gabriel
Journal:  Neurochem Res       Date:  2015-05-15       Impact factor: 3.996

2.  The hop cassette of the PAC1 receptor confers coupling to Ca2+ elevation required for pituitary adenylate cyclase-activating polypeptide-evoked neurosecretion.

Authors:  Tomris Mustafa; Maurizio Grimaldi; Lee E Eiden
Journal:  J Biol Chem       Date:  2007-01-09       Impact factor: 5.157

Review 3.  Pituitary adenylate cyclase-activating polypeptide receptors in the trigeminovascular system: implications for migraine.

Authors:  Tahlia Sundrum; Christopher S Walker
Journal:  Br J Pharmacol       Date:  2017-10-25       Impact factor: 8.739

Review 4.  Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance.

Authors:  John T Williams; Susan L Ingram; Graeme Henderson; Charles Chavkin; Mark von Zastrow; Stefan Schulz; Thomas Koch; Christopher J Evans; Macdonald J Christie
Journal:  Pharmacol Rev       Date:  2013-01-15       Impact factor: 25.468

5.  Neurotrophic actions of PACAP-38 and LIF on human neuroblastoma SH-SY5Y cells.

Authors:  T K Monaghan; C Pou; C J MacKenzie; R Plevin; E M Lutz
Journal:  J Mol Neurosci       Date:  2008-05-28       Impact factor: 3.444

6.  Characterisation of the mouse vasoactive intestinal peptide receptor type 2 gene, Vipr2, and identification of a polymorphic LINE-1-like sequence that confers altered promoter activity.

Authors:  G Steel; E M Lutz
Journal:  J Neuroendocrinol       Date:  2007-01       Impact factor: 3.627

7.  Lowe syndrome-linked endocytic adaptors direct membrane cycling kinetics with OCRL in Dictyostelium discoideum.

Authors:  Alexandre Luscher; Florian Fröhlich; Caroline Barisch; Clare Littlewood; Joe Metcalfe; Florence Leuba; Anita Palma; Michelle Pirruccello; Gianni Cesareni; Massimiliano Stagi; Tobias C Walther; Thierry Soldati; Pietro De Camilli; Laura E Swan
Journal:  Mol Biol Cell       Date:  2019-06-19       Impact factor: 4.138

Review 8.  Signal Transduction by VIP and PACAP Receptors.

Authors:  Ingrid Langer; Jérôme Jeandriens; Alain Couvineau; Swapnil Sanmukh; Dorota Latek
Journal:  Biomedicines       Date:  2022-02-09

9.  Alternative Splicing of the Pituitary Adenylate Cyclase-Activating Polypeptide Receptor PAC1: Mechanisms of Fine Tuning of Brain Activity.

Authors:  Janna Blechman; Gil Levkowitz
Journal:  Front Endocrinol (Lausanne)       Date:  2013-05-21       Impact factor: 5.555

10.  PACAP-38 induces neuronal differentiation of human SH-SY5Y neuroblastoma cells via cAMP-mediated activation of ERK and p38 MAP kinases.

Authors:  T K Monaghan; C J Mackenzie; R Plevin; E M Lutz
Journal:  J Neurochem       Date:  2007-11-06       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.